PTC Therapeutics Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Underweight to Equal-Weight and Raised Its Price Target From $28 to $30
摩根士丹利将该股从减持上调至等权重并将其目标股价从28美元上调至30美元后,PTC Therapeutics股价走高
PTC Therapeutics Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Underweight to Equal-Weight and Raised Its Price Target From $28 to $30
摩根士丹利将该股从减持上调至等权重并将其目标股价从28美元上调至30美元后,PTC Therapeutics股价走高
使用浏览器的分享功能,分享给你的好友吧